Unrated Drug recall · FDA · Published September 25, 2026

Houston Rx Recalls Sermorelin Vials Due to Lack of Process Control

Houston Rx LLC is recalling 7 vials of Sermorelin 1 mg/mL due to lack of process control. Check lot SER-081726-1-10 and beyond use date 10/01/2026.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0041-2027Drug Houston Rx LLC ›

Recall notice

Lack of process control

✎ GovInfoNow plain-language explainer

Houston Rx LLC has recalled a small quantity of Sermorelin sterile injectable solution because of a lack of process control. The recall affects only seven vials distributed nationwide in the USA. No specific remedy or injury details are provided in the record. Read more at govinfonow.com/recall/1756690-houston-rx-llc-recalls-sermorelin-1-mg-ml-10-ml.

Source Summary by GovInfoNow · govinfonow.com/recall/1756690-houston-rx-llc-recalls-sermorelin-1-mg-ml-10-ml · Published October 27, 2026 · Updated October 27, 2026 · FDA enforcement record: FDA #D-0041-2027

Cite this page

“Houston Rx Recalls Sermorelin Vials Due to Lack of Process Control.” GovInfoNow, updated October 27, 2026. https://govinfonow.com/recall/1756690-houston-rx-llc-recalls-sermorelin-1-mg-ml-10-ml. Based on FDA recall #D-0041-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0041-2027%22&limit=1).

The FDA announced on Sept. 25, 2026, that Houston Rx LLC voluntarily recalled Sermorelin Injectable Solution due to a lack of process control. The recall affects one lot distributed nationwide.

How to tell if you have it

Brand: Houston Rx LLC
Product: Sermorelin Injectable Solution, 1 mg/mL, 10 ml vial
Lot code: SER-081726-1-10
Beyond Use Date: 10/01/2026

The hazard

The product poses a hazard due to a lack of process control, according to the FDA.

Context

GovInfoNow's records show other recent recalls include Shoolin Pharma Chem Sildenafil Recall on Aug. 3, 2026, and Golden State Medical Recalls Prasugrel HCl 10mg Tablets on Aug. 21, 2026. Wells Pharma Fentanyl Citrate Injectable Solution Recall occurred on April 1, 2026.

How to tell if you have this one

Look for Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution. The recalled lot number is SER-081726-1-10 with a Beyond Use Date of 10/01/2026. It was distributed nationwide in the USA.

Brand
Houston Rx LLC
Category
Drug

FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class II
Status
Ongoing
Distribution
Nationwide in the USA.

Recall number	Product, codes & lots	Quantity
D-0040-2027	Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.; Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.	64 vials
D-0041-2027	Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.; Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026.	7 vials

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

Sep 25, 2026Firm started the recall
Oct 13, 2026FDA classified it Class II
Oct 21, 2026Published in FDA’s Enforcement Report
Oct 27, 2026Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/1756690-houston-rx-llc-recalls-sermorelin-1-mg-ml-10-ml">Houston Rx Recalls Sermorelin Vials Due to Lack of Process Control (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0041-2027 (September 25, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0041-2027 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 27, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.